Medicare Advantage Payment Proposal Sparks Mixed Reactions
This week, Medicare Advantage health plans are moving forward with a government proposal aimed at stabilizing reimbursement rates for the upcoming year. Among other changes, the Centers for Medicare and Medicaid Services (CMS) has suggested keeping these payment rates flat for 2027.
Interestingly, some health policy experts believe this plan could significantly reduce the billions lost to overbilling, a concern that’s been prevalent in the program for over a decade. It’s a bit controversial, the idea that stricter payment policies might actually save money in the long run.
On January 26, CMS officials indicated that payment rates for health plans would be substantially lower than what industry leaders had anticipated. This prompted a notable drop in stock prices for major insurance companies like UnitedHealth Group and Humana. As a result, various industry representatives have warned that without additional funding from the government, essential services for seniors could be at risk.
In essence, the federal government pays private insurance firms to handle medical care for individuals over 65 or those with disabilities. Yet, there’s more at play here. In an overlooked aspect of the fee discussion, CMS is also aiming to restrict health plans from conducting so-called “chart reviews.” These reviews can lead to new medical diagnoses—which patients may not even be seeking—thereby inflating the payments made to Medicare Advantage plans.
The use of chart reviews has drawn criticism from government auditors for years, who argue that they contribute to unacceptable overpayments. Recently, the Justice Department revealed that Kaiser Permanente, a nonprofit health system, had faced a substantial settlement for adding hundreds of thousands of diagnoses to patient records between 2009 and 2018, resulting in improper payments around the billion-dollar mark. They didn’t admit to any wrongdoing, though.
Spencer Perlman, a health policy analyst, mentioned that the administration seems committed to addressing these overpayments. It’s noteworthy that while the Trump administration has historically supported Medicare Advantage, its officials are increasingly concerned about practices that exploit medical records just to inflate profits.
CMS Administrator Mehmet Oz has stated that these proposals aim to ensure more accurate payments to health plans, ultimately protecting taxpayers from unnecessary expenditures that don’t genuinely address health needs. “These policies are crafted to improve Medicare Advantage for those it serves,” he remarked.
However, Richard Kronick, a former federal health policy researcher, remains skeptical about the actual impact of these changes. He believes that the industry will likely find ways to circumvent the new rules. It raises an interesting question—will the proposed restrictions really contribute to meaningful change, or will plans adapt and continue issuing overpayments?
Critics have pointed out that unregulated practices in medical coding could cost taxpayers dearly, suggesting that keeping seniors in Medicare Advantage plans is much more expensive than sticking with the traditional Medicare system. There’s been a dramatic increase in available insurance plans recently, with over 34 million members currently enrolled in Medicare Advantage.
Commenting on the potential fallout, Chris Bond, a spokesman for AHIP, warned that maintaining flat payment rates might lead to a reduction in benefits and rising costs for millions of seniors and individuals with disabilities who are renewed annually.
CMS is currently open for public feedback on this proposal, which is set to be finalized by early April. Some find themselves cautiously optimistic, like David Myers, who believes that the administration is indeed signaling a desire to cut inefficiencies in the system.
However, there’s a persistent concern. The health insurance industry has often used intensive lobbying and strategic communications to resist changes aimed at addressing overpayments. The question lingers: How effective will CMS be in navigating the complexities of this proposal? And will the industry’s responses lead to a rollback of any meaningful reforms?
In short, the next few months will be critical as the situation unfolds, and it’s hard to predict what the final outcome will be. But one thing’s for sure: the conversation surrounding Medicare Advantage is far from over.
